Abstract
Research on the nervous system has been intensified over the last decades and still is booming. Basic neuroscience has dramatically increased the knowledge of cellular and molecular mechanisms of brain functioning. As a result cellular and molecular disarrangements that go with the variety of neurological, neurodegenerative and psychiatric disorders have been identified, although the primary causes of these disorders remain largely unknown. In cases of acquired or degenerative loss of nervous functions, pharmacological treatments are still mainly directed towards the amelioration of symptoms and the limitation of secondary tissue damage. This clinical problem together with the development of new potential therapeutic techniques such as cell grafting or implantation and gene transfer, have led to the exploration of interventions in the nervous system that can tentatively be called “restorative neurosurgery”. A shift from animal experimentation to clinical trials occurred rapidly and experimental neurotransplantation surgery in patients with neurological and neurodegenerative disorders has taken place over several decades. Neuroscience, however, is just beginning to explore cellular and molecular interventions in diseased, degenerating or traumatised human nervous systems. Are we approaching an era of interventions in the brain that will revolutionise treatment of thus far untreatable brain disorders?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
In the case of gene therapy one can stop gene expression when the Tet-Off and Tet-On expression systems (Baron and Bujard 2000) are applied in the recombinant transgene. The expression of a putative therapeutic transgene will then be dependent on the activity of the inducible transcriptional activator doxycycline. In Tet-Off, doxycycline in the drinking water will block expression, in the Tet-On system expression will be on in the presence of this tetracycline derivative, and blocked when it is left out the drinking water.
The 2004 publication of Hwang et al., describing the first therapeutic cloning of human embryos by SCNT (Hwang et al. 2004), has recently been withdrawn because of fraud (Normile et al. 2006).
The case of fraud of the South Korean researcher Hwang Woo-suk in the report on the first establishment of therapeutic cloning of human embryonic stem cells must be seen as a shadow cast over all purported breakthroughs in cloning and stem-cell technology and a grave act that damages the very foundations of science. However, it should not be viewed as an argument to stop research in this field that had raised hopes of new cures for hard-to-treat diseases.
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2007). Neurotransplantation and Gene Transfer. In: Intervening in the Brain. Ethics of Science and Technology Assessment, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-46477-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-46477-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-46476-1
Online ISBN: 978-3-540-46477-8
eBook Packages: MedicineMedicine (R0)